Nymirum
Base4 focuses on rna-targeted therapeutics.
Launch date
Employees
Market cap
-
Enterprise valuation
€2—3m (Dealroom.co estimates May 2009.)
Ann Arbor Michigan (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$550k | Seed | ||
$2.8m | Grant | ||
| Total Funding | €3.0m | ||
Recent News about Nymirum
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.